Pasar al contenido principal

ABORDAJE DEL CANCER COMO UNA ENFERMEDAD BASADA EN LA INFLAMACION: DESARROLLO TEORICO DE FORMAS INNOVADORAS PARA DISEÑAR NUEVOS TRATAMIENTOS FARMACOLOGICOS Y FOTOFARMACOLOGICOS

PID2023-147140NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exploring allosteric properties of mammalian ALOX15, octyl (N -(4-(benzofuran-2-yl)-2-methoxyphenyl)sulfamoyl)- and octyl (N -(4-(1 H -indol-2-yl)-2-methoxyphenyl)sulfamoyl)carbamates as ALOX inhibitors

  • Gavrilyuk, Viktor|||0000-0002-1811-2380
  • Cruz Saez, Alejandro|||0000-0003-0928-0718
  • Aksenov, Vladislav
  • Nurgaliev, Danila
  • Zhuravlev, Alexander|||0000-0003-1189-8285
  • Golovanov, Alexey|||0000-0002-9198-2876
  • Lluch, José M.|||0000-0002-7536-1869
  • Kuhn, Hartmut|||0000-0001-8142-3192
  • Ivanov, Igor|||0000-0003-0543-2067
  • González Lafont, Àngels|||0000-0003-0729-2483
Mammalian ALOX15 are allosteric enzymes but the mechanism of allosteric regulation remains a matter of discussion. Octyl (N -(5-(1 H -indol-2-yl)-2-methoxyphenyl)sulfamoyl)carbamate inhibits the linoleate oxygenase activity of ALOX15 at nanomolar concentrations, but oxygenation of arachidonic acid is hardly affected. The mechanism of substrate selective inhibition suggests inter-monomer communication within the allosteric ALOX15 dimer complex, in which the inhibitor binding to monomer A induces conformational alterations in the structure of the active site of monomer B. Interactions of the NH-group of the indole moiety with the Fe()-OH - cofactor or of the SO group of the sulfocarbamate moiety with the side chain NH group of Gln596 may be important for proper inhibitor placement in the ALOX15 allosteric complex. Substitution of a H-bond donor to a H-bond acceptor (NH-O-exchange) impacts but does not eliminate the ability of the compound to inhibit preferentially the LA-oxygenase activity of ALOX15. In contrast, swapping the positions of CHO- and NH groups at the 2-aryl moiety led to a loss of substrate selective inhibition. In silico docking studies and molecular dynamics-simulations using a dimeric allosteric ALOX15 model have shown that binding of the substrate molecule to ALOX15 monomer B may alter the structure of the monomer A-inhibitor complex forcing the inhibitor to adopt a different binding mode. Taken together, this data suggests the possibility of two-way communication between ALOX15 monomers during enzymatic catalysis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents

  • Morales Jiménez, Amanda
  • Cruz, Alejandro
  • Pérez-Sánchez, Álex|||0000-0003-3636-3885
  • D'Avino, Danilo
  • Galassi, Gaia
  • Milano, Erica Ginevra
  • Bernareggi, Irene
  • Arenós-Bach, Carla|||0009-0002-0297-539X
  • Grazioso, Giovanni
  • Alibés, Ramon|||0000-0002-7997-2691
  • Hernando, Jordi|||0000-0002-1126-4138
  • Gorostiza, Pau|||0000-0002-7268-5577
  • Rossi, Antonietta
  • Pistocchi, Anna
  • Matera, Carlo|||0000-0001-6939-3859
  • Busqué, Félix|||0000-0001-7566-4264
  • González Lafont, Àngels|||0000-0003-0729-2483
  • Lluch, José M.|||0000-0002-7536-1869
Despite their extensive use, the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) remains significantly constrained by adverse side effects. This limitation primarily arises from insufficient selectivity, as current NSAIDs inhibit not only the inducible cyclooxygenase-2 (COX-2) isoform at sites of inflammation but also constitutive COX-2 in healthy tissues and, frequently, cyclooxygenase-1. To address this challenge, we developed photoswitchable NSAIDs that combine COX-2 selectivity with light-controlled activity to enable spatiotemporal confinement of the therapeutic effect at inflamed tissues. Following computational design and screening of a library of azoaromatic derivatives of celecoxib─the most widely used COX-2 selective NSAID─three photoswitchable analogues were synthesized, which exhibited reversible and efficient trans-cis photoconversion. Light-controlled and selective COX-2 inhibition was demonstrated for these compounds in vitro, reaching up to 5-fold potency enhancement in macrophage assays upon photoisomerization from the initial, dark-adapted trans isomer to the cis state. The best candidate displayed in vivo efficacy in a zebrafish model of acute inflammation, where administration of the photoinduced cis form reduced leukocyte recruitment at the wound site. These findings position photoswitchable NSAIDs as a promising alternative to conventional drugs for treating inflammation and related conditions, including cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Omega-3 DHA as a blank canvas, A molecular approximation to how lipid mediators modulate LGR6 in inflammation resolution

  • Pérez-Sánchez, Álex|||0000-0003-3636-3885
  • García Viloca, Mireia|||0000-0001-5415-0248
  • González Lafont, Àngels|||0000-0003-0729-2483
  • Lluch, José M.|||0000-0002-7536-1869
The leucine-rich repeat-containing G protein-coupled receptor 6 (LGR6) has a potential role in inflammation resolution and different cancer processes. In this study, we employed computational techniques, including molecular docking and molecular dynamics simulations of mammalian membrane-embeded systems, to understand the activation mechanism of LGR6 upon binding of the specialized pro-resolving lipid mediator maresin 1. Additionally, we investigated the interaction and the dynamics of other relevant lipid mediators (leukotriene B, protectin D1, and docosahexaenoic acid) to understand their influence on receptor activity. Our findings reveal different mediator-specific conformational changes in LGR6, suggesting hydroxyl positions at these mediators as the key factor by which maresin 1 and other lipid mediators modulate receptor activation and contribute to inflammation resolution.
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Exploring allosteric properties of mammalian ALOX15: octyl (N-(4-(benzofuran-2-yl)-2-methoxyphenyl)sulfamoyl)- and octyl (N-(4-(1H-indol-2-yl)-2-methoxyphenyl)sulfamoyl)carbamates as ALOX inhibitors

  • Gavrilyuk, Viktor
  • Cruz Sáez, Alejandro|||0000-0003-0928-0718
  • Aksenov, Vladislav
  • Nurgaliev, Danila
  • Zhuravlev, Alexander
  • Golovanov, Alexey
  • Lluch López, Josep Maria
  • Kuhn, Hartmut
  • Ivanov, Igor
  • González Lafont, Àngels
Mammalian ALOX15 are allosteric enzymes but the mechanism of allosteric regulation remains a matter of discussion. Octyl (N-(5-(1H-indol-2-yl)-2-methoxyphenyl)sulfamoyl)carbamate inhibits the linoleate oxygenase activity of ALOX15 at nanomolar concentrations, but oxygenation of arachidonic acid is hardly affected. The mechanism of substrate selective inhibition suggests inter-monomer communication within the allosteric ALOX15 dimer complex, in which the inhibitor binding to monomer A induces conformational alterations in the structure of the active site of monomer B. Interactions of the NH-group of the indole moiety with the Fe(III)–OH- cofactor or of the SO2 group of the sulfocarbamate moiety with the side chain NH2 group of Gln596 may be important for proper inhibitor placement in the ALOX15 allosteric complex. Substitution of a H-bond donor to a H-bond acceptor (NH–O-exchange) impacts but does not eliminate the ability of the compound to inhibit preferentially the LA-oxygenase activity of ALOX15. In contrast, swapping the positions of CH3O- and NH groups at the 2-aryl moiety led to a loss of substrate selective inhibition. In silico docking studies and molecular dynamics-simulations using a dimeric allosteric ALOX15 model have shown that binding of the substrate molecule to ALOX15 monomer B may alter the structure of the monomer A-inhibitor complex forcing the inhibitor to adopt a different binding mode. Taken together, this data suggests the possibility of two-way communication between ALOX15 monomers during enzymatic catalysis., Russian Ministry of Science and High Education (FSFZ-2023-0004) supported the experimental part of this work. We thank the Spanish “Ministerio de Ciencia, Innovación y Universidades” (Grant PID2020-113764GB-I00 and Grant PID2023-147140NB-I00). We also acknowledge CSUC for computational facilities as well as a Shared Science and training Center for Collective Use of RTU MIREA supported by the Ministry of Science and Higher Education by Agreement No. 075-15-2025-548., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Photoswitchable COX-2-selective inhibitors as light-regulated anti-inflammatory agents

  • Morales Jimenez, Amanda
  • Cruz Sáez, Alejandro|||0000-0003-0928-0718
  • Pérez Sánchez, Álex
  • D'Avino, Danilo
  • Galassi, Gaia
  • Ginevra Milano, Erica
  • Bernareggi, Irene
  • Arenós Bach, Carla
  • Grazioso, Giovanni|||0000-0002-3261-9356
  • Alibes Arques, Ramon
  • Hernando Campos, Jordi
  • Gorostiza Langa, Pau
  • Rossi, Antonietta
  • Pistocchi, Anna
  • Matera, Carlo
  • Busqué Sanchez, Felix
  • González Lafont, Àngels
  • Lluch López, Josep Maria
Despite their extensive use, the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) remains significantly constrained by adverse side effects. This limitation primarily arises from insufficient selectivity, as current NSAIDs inhibit not only the inducible cyclooxygenase-2 (COX-2) isoform at sites of inflammation but also constitutive COX-2 in healthy tissues and, frequently, cyclooxygenase-1. To address this challenge, we developed photoswitchable NSAIDs that combine COX-2 selectivity with light-controlled activity to enable spatiotemporal confinement of the therapeutic effect at inflamed tissues. Following computational design and screening of a library of azoaromatic derivatives of celecoxib-the most widely used COX-2 selective NSAID-three photoswitchable analogues were synthesized, which exhibited reversible and efficient trans-cis photoconversion. Light-controlled and selective COX-2 inhibition was demonstrated for these compounds in vitro, reaching up to 5-fold potency enhancement in macrophage assays upon photoisomerization from the initial, dark-adapted trans isomer to the cis state. The best candidate displayed in vivo efficacy in a zebrafish model of acute inflammation, where administration of the photoinduced cis form reduced leukocyte recruitment at the wound site. These findings position photoswitchable NSAIDs as a promising alternative to conventional drugs for treating inflammation and related conditions, including cancer., This work was supported by the “Ministerio de Ciencia, Innovación y Universidades” of Spain through projects PID2019-111493RB-I00, PID2022-142609OB-I00, PID2023-147140NB-I00, and PID2022-139826OB-I00. We also acknowledge CSUC (“Consorci de Serveis Universitaris de Catalunya”) for the allocation of computing resources, as well as from Generalitat de Catalunya through projects 2021 SGR 00064 and 2021 SGR 01410 and CERCA program. This study was supported by funds from the University of Milan, Piano di Sostegno alla Ricerca 2025, Linea 2. This research was supported for the in vitro studies by the Italian Ministry of University and Research (PRIN 2022 PNRR; MIUR CODE: P2022CNPH8, CUP: C53D23007850001). This research also received funding from the European Union Research and Innovation Program Horizon 2020 – Human Brain Project SG3 (945539), DEEPER (ICT-36-2020-101016787), and the European Innovation Council Pathfinder Open (PHOTOTHERAPORT, 101130883). J.H. is a Serra Húnter fellow., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Exploring allosteric properties of mammalian ALOX15: octyl (N-(4-(benzofuran-2-yl)-2-methoxyphenyl)sulfamoyl)- and octyl (N-(4-(1H-indol-2-yl)-2-methoxyphenyl)sulfamoyl)carbamates as ALOX inhibitors

  • Gavrilyuk, Viktor
  • Cruz Sáez, Alejandro
  • Aksenov, Vladislav
  • Nurgaliev, Danila
  • Zhuravlev, Alexander
  • Golovanov, Alexey
  • Lluch López, Josep Maria
  • Kuhn, Hartmut
  • Ivanov, Igor
  • González Lafont, Àngels
Mammalian ALOX15 are allosteric enzymes but the mechanism of allosteric regulation remains a matter of discussion. Octyl (N-(5-(1H-indol-2-yl)-2-methoxyphenyl)sulfamoyl)carbamate inhibits the linoleate oxygenase activity of ALOX15 at nanomolar concentrations, but oxygenation of arachidonic acid is hardly affected. The mechanism of substrate selective inhibition suggests inter-monomer communication within the allosteric ALOX15 dimer complex, in which the inhibitor binding to monomer A induces conformational alterations in the structure of the active site of monomer B. Interactions of the NH-group of the indole moiety with the Fe(III)–OH- cofactor or of the SO2 group of the sulfocarbamate moiety with the side chain NH2 group of Gln596 may be important for proper inhibitor placement in the ALOX15 allosteric complex. Substitution of a H-bond donor to a H-bond acceptor (NH–O-exchange) impacts but does not eliminate the ability of the compound to inhibit preferentially the LA-oxygenase activity of ALOX15. In contrast, swapping the positions of CH3O- and NH groups at the 2-aryl moiety led to a loss of substrate selective inhibition. In silico docking studies and molecular dynamics-simulations using a dimeric allosteric ALOX15 model have shown that binding of the substrate molecule to ALOX15 monomer B may alter the structure of the monomer A-inhibitor complex forcing the inhibitor to adopt a different binding mode. Taken together, this data suggests the possibility of two-way communication between ALOX15 monomers during enzymatic catalysis., Russian Ministry of Science and High Education (FSFZ-2023-0004) supported the experimental part of this work. We thank the Spanish “Ministerio de Ciencia, Innovación y Universidades” (Grant PID2020-113764GB-I00 and Grant PID2023-147140NB-I00). We also acknowledge CSUC for computational facilities as well as a Shared Science and training Center for Collective Use of RTU MIREA supported by the Ministry of Science and Higher Education by Agreement No. 075-15-2025-548., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Photoswitchable COX-2-selective inhibitors as light-regulated anti-inflammatory agents

  • Morales Jimenez, Amanda
  • Cruz Sáez, Alejandro
  • Pérez Sánchez, Álex
  • D'Avino, Danilo
  • Galassi, Gaia
  • Ginevra Milano, Erica
  • Bernareggi, Irene
  • Arenós Bach, Carla
  • Grazioso, Giovanni
  • Alibes Arques, Ramon
  • Hernando Campos, Jordi
  • Gorostiza Langa, Pau
  • Rossi, Antonietta
  • Pistocchi, Anna
  • Matera, Carlo
  • Busqué Sanchez, Felix
  • González Lafont, Àngels
  • Lluch López, Josep Maria
Despite their extensive use, the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) remains significantly constrained by adverse side effects. This limitation primarily arises from insufficient selectivity, as current NSAIDs inhibit not only the inducible cyclooxygenase-2 (COX-2) isoform at sites of inflammation but also constitutive COX-2 in healthy tissues and, frequently, cyclooxygenase-1. To address this challenge, we developed photoswitchable NSAIDs that combine COX-2 selectivity with light-controlled activity to enable spatiotemporal confinement of the therapeutic effect at inflamed tissues. Following computational design and screening of a library of azoaromatic derivatives of celecoxib-the most widely used COX-2 selective NSAID-three photoswitchable analogues were synthesized, which exhibited reversible and efficient trans-cis photoconversion. Light-controlled and selective COX-2 inhibition was demonstrated for these compounds in vitro, reaching up to 5-fold potency enhancement in macrophage assays upon photoisomerization from the initial, dark-adapted trans isomer to the cis state. The best candidate displayed in vivo efficacy in a zebrafish model of acute inflammation, where administration of the photoinduced cis form reduced leukocyte recruitment at the wound site. These findings position photoswitchable NSAIDs as a promising alternative to conventional drugs for treating inflammation and related conditions, including cancer., This work was supported by the “Ministerio de Ciencia, Innovación y Universidades” of Spain through projects PID2019-111493RB-I00, PID2022-142609OB-I00, PID2023-147140NB-I00, and PID2022-139826OB-I00. We also acknowledge CSUC (“Consorci de Serveis Universitaris de Catalunya”) for the allocation of computing resources, as well as from Generalitat de Catalunya through projects 2021 SGR 00064 and 2021 SGR 01410 and CERCA program. This study was supported by funds from the University of Milan, Piano di Sostegno alla Ricerca 2025, Linea 2. This research was supported for the in vitro studies by the Italian Ministry of University and Research (PRIN 2022 PNRR; MIUR CODE: P2022CNPH8, CUP: C53D23007850001). This research also received funding from the European Union Research and Innovation Program Horizon 2020 – Human Brain Project SG3 (945539), DEEPER (ICT-36-2020-101016787), and the European Innovation Council Pathfinder Open (PHOTOTHERAPORT, 101130883). J.H. is a Serra Húnter fellow., Peer Reviewed, Postprint (published version)